Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03894917 · ClinicalTrials.gov registry record
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
A clinical trial of Carcinoma, Hepatocellular, sponsored by The University of Texas Health Science Center at San Antonio.
- Recruiting
- Registry status
- 84
- Enrollment target
- 1
- Study location
NCT03894917: Recruiting study of Carcinoma, Hepatocellular, sponsored by The University of Texas Health Science Center at San Antonio.
NCT03894917 is a study of Carcinoma, Hepatocellular that is actively recruiting participants, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 84 participants, below the 609-participant average among 27 other Carcinoma, Hepatocellular trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03894917, a study of Carcinoma, Hepatocellular, is actively recruiting participants, sponsored by The University of Texas Health Science Center at San Antonio.
- RECRUITING
- Registry status
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational, prospective cohort study that will recruit a diverse sample of 84 participants with newly diagnosed with unresectable, advanced hepatocellular carcinoma (HCC) at the UT Health Cancer Center in San Antonio. This study uses geriatric assessment tools with participants 65 years and older and collects adverse events and exploratory markers of aging for all participants.
Primary Outcome
Collection of the participants disease characteristics, clinical and treatment data. Comprehensive geriatrics assessments will be done using bilingual assessments in English and Spanish.
Conditions Studied
Interventions
- OTHER Comprehensive Geriatric Assessment (CGA)
Study Locations (1)
Texas
- Mays Cancer Center - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2019-09-13 |
| Est. Completion | 2027-12 |
What NCT03894917 shows while recruiting
NCT03894917 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 609-participant average among 27 other Carcinoma, Hepatocellular trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Carcinoma, Hepatocellular appearing as the primary indexed condition, and to 1 intervention - of which Comprehensive Geriatric Assessment (CGA) is the first listed.
NCT03894917 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03894917 about?
NCT03894917 is a clinical study titled "Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma". This is an observational, prospective cohort study that will recruit a diverse sample of 84 participants with newly diagnosed with unresectable, advanced hepatocellular carcinoma (HCC) at the UT Health Cancer Center in San Antonio. This study uses geriatric assessment tools with participants 65 year...
What is the current status of trial NCT03894917?
This trial is currently recruiting. The enrollment target is 84 participants. The study started on 2019-09-13. Estimated completion is 2027-12.
What conditions does trial NCT03894917 study?
This clinical trial studies the following conditions: Carcinoma, Hepatocellular.
What interventions are being tested in trial NCT03894917?
The interventions under investigation include: Comprehensive Geriatric Assessment (CGA) (OTHER).
Who is sponsoring clinical trial NCT03894917?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03894917 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carcinoma, Hepatocellular
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03894917's enrollment target sits among peer trials
84 14th of 27 higher than 14 of 27 other Carcinoma, Hepatocellular trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Carcinoma, Hepatocellular trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
90Y Transarterial Radioembolization Versus Microwave Ablation in Small Hepatocellular Carcinoma With Hypoalbuminemia
RECRUITING · NA
-
National Liver Cancer Screening Trial
RECRUITING · Phase 4
-
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
RECRUITING · NA
-
ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma
RECRUITING · Phase 1
-
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
RECRUITING
-
Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT04245748 · 84 participants · Phase 4
Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI